Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Unmet Need of Objective Monitor to Evaluate Performance Status in Lung Cancer Patients


Affiliations
1 Assistant Professor, School of Bioengineering Sciences and Research, MIT-ADT University, Loni Kalbhor, Pune, India
2 Assistant Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
3 Medical Oncologist, Curie Abdur Razzaque Ansari Cancer Institute, Ranchi, Jharkhand, India
4 Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
     

   Subscribe/Renew Journal


Context: Quality of life (QOL) of lung cancer patients can be improved by using modern technical tools. There is a necessity to develop a system which incorporates all the functions to evaluate severity of the disease and critical condition of the patients. There exists a need of an objective monitor for monitoring performance of lung cancer patients with parameters of HRV, SPO2 and Peak Expiratory Flow Rate (PEFR). A questionnaire-based survey was carried out in cancer physicians, surgeons and radiotherapists. Total 100 clinicians participated in this questionnaire, 35 medical oncologists, 35 oncosurgeons and 40 radiation oncologists. The analysis of this survey showed that presently ECOG (Eastern Cooperative Oncology Group) scale was preferred to KPS (Karnofsky Performance Status) scale (70% versus 30%) because of simplicity to remember. The popular parameters preferred among clinicians were SPO2 (45%), 2D Echocardiography (30%), chest X-ray (42%). But for HRV test, all the clinicians (100%) rejected the availability of test facilities. SPO2 and PEFR were also rated as mobile tools for assessing the performance. ECOG Scale was easier to utilize than KPS for understanding the performance Status in cancer patients. It is suggested that HRV, SPO2 and PEFR could be an added value to improve the QOL in cancer patients.

Keywords

KPS, ECOG, Monitor, Questionnaire, PEFR, SPO2.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 61

PDF Views: 0




  • Unmet Need of Objective Monitor to Evaluate Performance Status in Lung Cancer Patients

Abstract Views: 61  |  PDF Views: 0

Authors

Reema Shyamsunder Shukla
Assistant Professor, School of Bioengineering Sciences and Research, MIT-ADT University, Loni Kalbhor, Pune, India
Yogender Aggarwal
Assistant Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
Yogender Aggarwal
Assistant Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
Shreeniwas Sheelawant Raut
Medical Oncologist, Curie Abdur Razzaque Ansari Cancer Institute, Ranchi, Jharkhand, India
Shreeniwas Sheelawant Raut
Medical Oncologist, Curie Abdur Razzaque Ansari Cancer Institute, Ranchi, Jharkhand, India
Rakesh Kumar Sinha
Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
Rakesh Kumar Sinha
Professor, Bio-Engineering Department, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India

Abstract


Context: Quality of life (QOL) of lung cancer patients can be improved by using modern technical tools. There is a necessity to develop a system which incorporates all the functions to evaluate severity of the disease and critical condition of the patients. There exists a need of an objective monitor for monitoring performance of lung cancer patients with parameters of HRV, SPO2 and Peak Expiratory Flow Rate (PEFR). A questionnaire-based survey was carried out in cancer physicians, surgeons and radiotherapists. Total 100 clinicians participated in this questionnaire, 35 medical oncologists, 35 oncosurgeons and 40 radiation oncologists. The analysis of this survey showed that presently ECOG (Eastern Cooperative Oncology Group) scale was preferred to KPS (Karnofsky Performance Status) scale (70% versus 30%) because of simplicity to remember. The popular parameters preferred among clinicians were SPO2 (45%), 2D Echocardiography (30%), chest X-ray (42%). But for HRV test, all the clinicians (100%) rejected the availability of test facilities. SPO2 and PEFR were also rated as mobile tools for assessing the performance. ECOG Scale was easier to utilize than KPS for understanding the performance Status in cancer patients. It is suggested that HRV, SPO2 and PEFR could be an added value to improve the QOL in cancer patients.

Keywords


KPS, ECOG, Monitor, Questionnaire, PEFR, SPO2.



DOI: https://doi.org/10.37506/v11%2Fi2%2F2020%2Fijphrd%2F194756